Compounds That Target CAMK4

Calcium/calmodulin-dependent protein kinase type IV · 14 compounds in BiohacksAI corpus

CAMK4 (Calcium/calmodulin-dependent protein kinase type IV) is a protein kinase involved in intracellular signal transduction. Kinases phosphorylate downstream substrates to regulate cell growth, survival, and metabolism. The 14 compounds targeting CAMK4 include both pharmaceutical inhibitors and natural compounds with evidence of kinase modulation, ranked by evidence strength from the BiohacksAI corpus.

View CAMK4 target page →

All 14 Compounds — Ranked by Evidence

Alvocidib

4.52

confidence

Ruxolitinib

4.23

confidence

Ceritinib

4.19

confidence

Nintedanib

3.61

confidence

Tae 684

3.43

confidence

Gilteritinib

3.40

confidence

Dabrafenib

3.30

confidence

Lestaurtinib

3.04

confidence

Pf 03758309

3.00

confidence

Gsk 690693

2.64

confidence

Ast 487

2.56

confidence

Merestinib

2.48

confidence

Su 014813

2.20

confidence

Amg 900

2.08

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for CAMK4 (Calcium/calmodulin-dependent protein kinase type IV). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: CAMK4 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.